Latest ABT news

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Investment Research · Wed, 23 Sep 2026 10:01:15 -0400

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health

PRNewsWire · Wed, 23 Sep 2026 07:00:00 -0400

Partnership combines Abbott's Lingo continuous glucose monitor with Berry Street's insurance-covered registered dietitian support, helping consumers translate glucose insights into healthier behaviors Research shows registered dietitian-led medical nutrition therapy can improve glucose control and cardiometabolic health outcomes, highlighting the power of combining glucose data plus human expertise1 ABBOTT PARK, Ill. and NEW YORK, Sept.

Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth

The Motley Fool · Mon, 21 Sep 2026 15:07:01 -0400

Abbott Laboratories (ABT +0.54%) primarily generates its revenue by researching, developing, manufacturing, and distributing a diverse portfolio of medical devices, diagnostic test systems, nutritional formulas, and generic pharmaceutical products across international healthcare networks.

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks Investment Research · Mon, 21 Sep 2026 09:56:06 -0400

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

3 Dividend Stocks to Buy and Hold for 10 Years

The Motley Fool · Fri, 18 Sep 2026 18:13:01 -0400

Pfizer has a deep pipeline that could help improve its approved lineup and financial results over the medium term. Abbott Laboratories' core medical device business remains strong, and the company has attractive opportunities elsewhere.

The Dividend Kings Ranked By Quality Scores (September 2026)

Seeking Alpha · Fri, 18 Sep 2026 08:16:11 -0400

Dividend Kings have a 50+ year track record of increasing dividends, showcasing resilience through economic challenges. I rank the Dividend Kings using my 9F Quality Scores, blending qualitative and quantitative factors for a robust, investment-grade assessment. ADP stands out as the best total-return candidate. It is undervalued, high-quality, and offering a strong projected dividend growth rate and Adjusted Chowder Number.

Why Wall Street Is Becoming Even More Bullish About This Dividend King

The Motley Fool · Fri, 18 Sep 2026 05:00:00 -0400

Wall Street analysts have raised price targets on Abbott, citing accelerating growth in its Medical Devices segment. Abbott's diabetes, electrophysiology, and new Exact Sciences cancer-screening businesses are driving stronger sales and earnings.

Market information is provided for research and visualization and is not investment advice.